JAZZ Jazz Pharmaceuticals, Inc.

XNAS 233.95 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

JAZZ $233.95 —

What changed

Recent filings, trades and moves
Key stats
$233.95
52-Week Range
$156.95 – $266.38
YTD
+35.11%
IV Rank (30D)
23.07
Straddle Price
$15.95
P/C Vol Ratio
3.89
Market Cap
$15.9B
Open
$247.98
Day Range
$233.64 – $247.98
Volume
761,766
Prev Close
$247.77
Fair Value
MODEL: NEUTRAL

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.15%
Beta vs SPY0.68
Cost of Equity (CAPM)8.57% (VRP-adj)
WACC7.71%
Volatility Risk Premium+39.4pp (IV − HV30)
Effective Tax Rate20.7%
Rev. Growth (YoY, DCF input)+3.8%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.04 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$1.5B
Return on Equity (TTM)4.9%
Book / Price26.9%
Gross Margin (TTM)89.1%
FCF Margin (TTM)32.7%
Debt / Equity1.09
Quality Score3/6 — normal (10y DCF)
Market-Implied Growth-5.9% (reverse-DCF on current price)
SMA 50$229.00 (Market Anchor value)
SMA 20 / Bollinger Mid$226.13
Bollinger Width / SMA2026.4% (drives anchor stability)
Net Debt$2.5B
Market Cap$16B
Peers used for multiples: ABBV, BMY, JNJ, LLY, MRK, PFE, VTRS, ZTS
60-Day Conviction
24%
20-Day Fair Value
≈ by Dec 17, 2026
$247.70
α -0.0% rank 28%
conviction
3%
40-Day Fair Value
≈ by Jan 15, 2027
$249.31
α +0.6% rank 42%
conviction
42%
60-Day Fair Value
≈ by Feb 15, 2027
$248.94
α +0.5% rank 35%
conviction
24%
MethodImplied PriceWeightDetail
DCF $469.18 21%
DDM (Gordon) n/a 0%
Peer P/E $136.37 5% median 42.3× · 7 peers
Peer EV/EBITDA $422.16 6% median 15.5× · 8 peers
Peer P/B $513.77 8% median 7.9× · 7 peers
Peer P/S $336.72 8% median 4.5× · 8 peers
Market Anchor (SMA50) $229.00 31% stability 74% (BB-width)
Options Expected (B-L 30d) $243.23 21% 26 strikes · skew +0.78
As of 2026-11-18 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$15.9B
Employees
2,890
List Date
2007-06-01
CIK
0001232524
Last Earnings
Nov 2 after close · +7.1% vs ±9.6% expected
Headquarters
Dublin
Homepage
https://www.jazzpharmaceuticals.com

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart

Markers: Click a marker type to show or hide it. Earnings turn amber when the stock moved more than options implied; hollow markers are still to come, or insider trades under a 10b5-1 plan. Intraday times are New York time; shaded bars are pre-market and after-hours.

Seasonality
Month'21'22'23'24'25'26Avg
Jan-3.05%6.03%0.19%-3.32%0.49%-5.00%-0.78%
Feb8.25%-2.39%-11.01%-3.86%17.68%13.59%3.71%
Mar-2.62%13.94%4.14%1.32%-11.46%-0.74%0.76%
Apr-0.48%0.83%-3.40%-6.92%-6.42%7.83%-1.43%
May7.87%-4.84%-9.34%-4.59%-7.77%16.66%-0.33%
Jun1.13%5.73%-3.99%0.94%-2.00%3.58%0.90%
Jul-6.44%-1.59%5.06%3.55%4.74%6.58%1.98%
Aug-22.85%2.77%10.67%1.40%10.59%-0.36%0.37%
Sep-1.33%-15.18%-9.96%1.91%1.65%-5.00%-4.65%
Oct2.36%6.16%-0.56%0.91%0.54%-7.31%0.35%
Nov-11.76%7.76%-7.15%10.09%27.57%15.54%*7.01%
Dec5.15%1.77%3.27%1.29%-1.23%--2.05%
Total-24.95%19.48%-22.07%1.65%32.10%50.79%9.50%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $228.87
SMA 50: $229.00
SMA 200: $221.51
Current: $233.84
EMA 12: $237.11
EMA 26: $231.94
MACD: 5.1686 | Signal: 1.3021
BULLISH
ADX (14): 29.43
TREND
+DI: 25.35
−DI: 20.27

Momentum Oscillators

RSI (14): 51.58
NEUTRAL
Stoch %K: 76.31
Stoch %D: 80.11
Williams %R: -44.64

Volume & Volatility

BB Upper: $258.87
BB Lower: $198.87
NEUTRAL
OBV: 42,573,619
Vol SMA 20: 787,602
Vol ROC: 11.45%
ATR: $7.89
True Range: $14.34
HV 20: 47.6%
HV 30: 42.2%
HV 60: 34.7%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-20T00:00:00 – 2026-11-18T00:00:00
AI Analysis
Written before JAZZ’s Nov 2 earnings report, so it doesn’t reflect the results.

LLM Stock Analysis Report: JAZZ

Executive Summary

Overall Assessment: NEUTRAL (6/10) - The stock is in a range-bound phase, with no clear trend direction or strong momentum signals. Key drivers include the recent acquisition of Actio and the potential catalysts from upcoming earnings and product launches.

Key Risks:

  1. Beta: 0.53 - low volatility relative to market
  2. Trend Indicators: Range-bound regime, with SMA 20 and EMA 12 indicating a neutral trend

Recent News Sentiment Impact: Positive (60%) - Headlines have been generally upbeat, driven by the acquisition of Actio and updates on product development.

Technical Analysis

Trend Direction: Neutral (Range-bound)

Support/Resistance Levels:

  • Upper Resistance: $257.11 (Bollinger Band Upper)
  • Middle Resistance: $246.54 (SMA 20)
  • Lower Support: $235.97 (Bollinger Band Lower)

Momentum Signals:

  • RSI (14): 43.64 (Neutral) - not overbought or oversold
  • MACD: Bearish signal line crossover (-2.03 / -0.41 / -1.62)
  • Bollinger Bands: Neutral signal, with price touching the middle band

Volume Analysis:

  • Volume SMA 20: 1103860.10 (Neutral) - not overly bullish or bearish
  • On-Balance Volume (OBV): 46942412.40 (Upward trending)
  • Volume Rate of Change: 336.29% (Bullish)

News & Sentiment Analysis

Recent Headlines Summary:

  1. Positive news from acquisition and product updates (60%)
  2. Neutral comments on market trends and analyst opinions (20%)
  3. Negative sentiment from earnings misses and regulatory issues (10%)

Sentiment Assessment: 55% Positive (Moderate sentiment)

Catalyst Identification:

  • Earnings Date: Upcoming earnings release potentially catalyzing the stock
  • Product Launches: Updates on product development and launches could drive price movements

Risk & Volatility Assessment

Risk Metrics:

  • Beta: 0.53 (Low) - stock moves less than market
  • Volatility Regime: Low volatility relative to historical levels

Options Market Signals:

  • IV Rank: 21.1% (Low) - shows if volatility is historically high/low
  • Current IV: 53.3%
  • Expected Move: $13.10 (28 DTE), 7-DTE: $2.52 - Options market pricing a potential move

Market Context & Positioning

Sector Performance:

  • JAZZ's sector is relatively strong, with a moderate upward trend

Institutional Activity:

  • Volume Patterns: Institutional interest seems moderate, with no clear trend direction

Correlation Analysis:

  • R-squared Interpretation: Correlated with market movements (0.19)

Relative Valuation:

  • Position within Trading Range: Neutral - not significantly overbought or oversold

Key Levels & Action Items

Critical Price Levels:

  • Support/Resistance: $257.11, $246.54, and $235.97 as mentioned above

Breakout/Breakdown Levels:

  • Uptrend Breakout: Above $257.11 (Upper Bollinger Band)
  • Downtrend Breakdown: Below $235.97 (Lower Bollinger Band)

Time-Sensitive Catalysts:

  • Earnings Date: Upcoming earnings release potentially catalyzing the stock

Risk Management:

  • Stop-loss Levels: Consider placing a stop-loss order around $234.50 (1.5% below Lower Bollinger Band)
  • Position Sizing: Be cautious with position sizing, considering the low volatility and moderate institutional interest
Generated
Earnings History
21 of 27 under expected move
Avg Expected Move
7.60%
Avg Actual Move
4.67%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-01-12 After-Close 3.40% 0.97% 0.29x Within
2021-04-20 After-Close 3.81% 1.01% 0.27x Within
2021-08-03 After-Close 7.41% 10.47% 1.41x Exceeded
2021-11-09 After-Close 7.97% 3.27% 0.41x Within
2022-01-10 After-Close 4.98% 2.22% 0.45x Within
2022-03-01 After-Close 8.74% 12.05% 1.38x Exceeded
2022-05-04 After-Close 10.19% 2.67% 0.26x Within
2022-08-03 After-Close 7.45% 0.32% 0.04x Within
2022-11-09 After-Close 6.82% 7.07% 1.04x Exceeded
2023-01-09 After-Close 5.47% 0.12% 0.02x Within
2023-03-01 After-Close 7.83% 2.73% 0.35x Within
2023-05-10 After-Close 6.41% 0.41% 0.06x Within
2023-08-09 After-Close 6.95% 1.64% 0.24x Within
2023-11-08 After-Close 7.25% 9.14% 1.26x Exceeded
2024-01-08 After-Close 7.39% 2.49% 0.34x Within
2024-02-28 After-Close 9.29% 8.33% 0.90x Within
2024-05-01 After-Close 7.73% 0.92% 0.12x Within
2024-07-31 After-Close 10.16% 3.75% 0.37x Within
2024-11-06 After-Close 6.95% 6.75% 0.97x Within
2025-01-13 After-Close 4.57% 0.16% 0.04x Within
2025-05-06 After-Close 8.64% 8.75% 1.01x Exceeded
2025-08-05 After-Close 11.75% 6.42% 0.55x Within
2025-11-05 After-Close 9.55% 2.31% 0.24x Within
2026-02-24 After-Close 8.92% 13.23% 1.48x Exceeded
2026-05-05 After-Close 7.94% 7.68% 0.97x Within
2026-08-03 After-Close 8.05% 3.99% 0.50x Within
2026-11-02 After-Close 9.61% 7.13% 0.74x Within

Earnings calendar: this week’s reports with expected vs actual moves →

JAZZ Options Activity & IV Rank

JAZZ IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 29.7%
7-DTE IV: —
Expected Move: $15.95
7-DTE Move: $6.72
Days to Exp: 29 (2026-12-18)

Options Flow · All expiries

Call Volume: 593
Put Volume: 2,307
P/C Volume: 3.89
BEARISH
Call OI: 6,487
Put OI: 3,870
P/C OI: 0.597
Total OI: 10,357

ATM Options Pricing

ATM Call: $10.85
ATM Put: $5.10
Call %: 4.6%
Put %: 2.2%

Chain Summary

Chain Volume: 2,900
Chain OI: 10,357
Last Updated: 11/19/2026

JAZZ Implied Volatility

30-day IV
29.7%
Nov 19
IV rank
23Low
Within its 90-session range

Loading implied volatility…

The 30-day IV is the at-the-money implied volatility of options 30 days out, the blue line. The band is its 20-session average, 2 standard deviations either side. Realized volatility is how much JAZZ actually moved over the last 20 sessions, from closing prices, on the same yearly scale. Without earnings takes each earnings report out of the 30-day IV, sized from what options paid for past reports, so it shows whether options are expensive or cheap apart from the report. Click a name above the chart to show or hide it.

Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 100th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
100%
vs own history
GEX tilt
+0.91
OI-weighted, today
Vanna tilt
+0.45
δ-sensitivity to IV
Charm tilt
+0.19
δ-decay vs time
Vanna tilt +0.45: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 37 ATM contracts, 5k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Put vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol points

The same measure on the upside: how the OTM call is priced against the at-the-money strike.

  • Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
  • Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together

Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put —
— pts EXTREME
No data
30 DTE / 10d put 44%
+7.0 pts EXTREME
ATM 29.0% / Put 36.0%

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)23.1LowNov 19

Embed JAZZ IV rank

JAZZ's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview
Straddle Price (30 DTE)$15.95Nov 19
Beta Analysis

Risk Metrics

Beta: 0.7073
Alpha: 29.11%
Correlation: 0.3007
R-Squared: 9.0%
Stock Volatility: 32.4%
Market Volatility: 13.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own JAZZ
5 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$391.3M
0.22%
#69 of 6285+146.5%13F
Millennium Management Hedge fund
Izzy Englander
$223.4M
0.15%
#109 of 3716-77.2%13F
Renaissance Technologies Hedge fund
Jim Simons
$112.0M
0.15%
#139 of 3151-14.0%13F
Rockefeller Capital Management Family office
Rockefeller family
$37.3M
0.05%
#318 of 4858-3.9%13F
Point72 Hedge fund
Steve Cohen
$2.6M
0.00%
#1201 of 1945-62.5%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

JAZZ Institutional Ownership (13F)

Filings for 2026-09-30
Diluted shares outstanding: 65,081,000 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

715 filers936,051,837 shares$16.65B value1438.29% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 29,845,463 $1.53B 9.20% 45.86% 2026-09-30
2 FMR LLC Custodian 16,414,326 $1.13B 6.79% 25.22% 2026-06-30
3 Vanguard Portfolio Management LLC 3,071,767 $711.18M 4.27% 4.72% 2026-09-30
4 Vanguard Capital Management LLC 2,805,176 $649.45M 3.90% 4.31% 2026-09-30
5 Capital World Investors 3,474,393 $555.87M 3.34% 5.34% 2026-09-30
6 State Street Corp 26,519,988 $518.41M 3.11% 40.75% 2026-09-30
7 LSV ASSET MANAGEMENT 2,135,935 $494.51M 2.97% 3.28% 2026-09-30
8 Franklin Resources, Inc. Custodian 13,443,969 $475.04M 2.85% 20.66% 2026-09-30
9 Citadel Advisors LLC Custodian 88,131,676 $391.31M 2.35% 135.42% 2026-06-30
10 AQR Capital Management, LLC Custodian 1,522,568 $359.94M 2.16% 2.34% 2026-06-30
11 Geode Capital Management, LLC Custodian 1,532,561 $354.89M 2.13% 2.35% 2026-09-30
12 Dimensional Fund Advisors LP Custodian 1,453,265 $336.46M 2.02% 2.23% 2026-09-30
13 FULLER & THALER ASSET MANAGEMENT, INC. 1,398,444 $323.77M 1.94% 2.15% 2026-09-30
14 Ameriprise Financial, Inc. Custodian 9,215,523 $306.61M 1.84% 14.16% 2026-06-30
15 Bank of America Corp Custodian 1,136,091 $273.76M 1.64% 1.75% 2026-06-30
16 JPMorgan Chase & Co Custodian 17,481,774 $263.46M 1.58% 26.86% 2026-09-30
17 Bank of New York Mellon Corp Custodian 1,352,150 $244.08M 1.47% 2.08% 2026-09-30
18 Swedbank AB 994,992 $230.36M 1.38% 1.53% 2026-09-30
19 VOYA INVESTMENT MANAGEMENT LLC 134,401,964 $227.38M 1.37% 206.51% 2026-09-30
20 Invesco Ltd. Custodian 3,681,451 $225.85M 1.36% 5.66% 2026-09-30
21 Millennium Management LLC Custodian 23,763,880 $223.35M 1.34% 36.51% 2026-06-30
22 BNP PARIBAS ASSET MANAGEMENT Holding S.A. 7,820,106 $201.23M 1.21% 12.02% 2026-09-30
23 Victory Capital Management Inc. 836,836 $193.74M 1.16% 1.29% 2026-09-30
24 Morgan Stanley Custodian 6,862,600 $173.09M 1.04% 10.54% 2026-09-30
25 Norges Bank 656,843 $158.28M 0.95% 1.01% 2026-06-30
9 filers$53.46M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $18.92M 35.39% 2026-06-30
2 Citadel Advisors LLC Custodian $11.25M 21.05% 2026-06-30
3 Caption Management, LLC $7.11M 13.30% 2026-06-30
4 Jane Street Group, LLC Custodian $4.68M 8.75% 2026-09-30
5 Walleye Capital LLC Custodian $4.38M 8.19% 2026-09-30
6 IMC-Chicago, LLC Custodian $3.24M 6.06% 2026-09-30
7 Lombard Odier Asset Management (Europe) Ltd $3.23M 6.04% 2026-06-30
8 Simplex Trading, LLC Custodian $463.04K 0.87% 2026-09-30
9 Point72 Asset Management, L.P. $192.78K 0.36% 2026-06-30
9 filers$39.73M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $22.87M 57.56% 2026-06-30
2 Citadel Advisors LLC Custodian $7.78M 19.59% 2026-06-30
3 Jane Street Group, LLC Custodian $2.34M 5.89% 2026-09-30
4 Point72 Asset Management, L.P. $1.76M 4.43% 2026-06-30
5 IMC-Chicago, LLC Custodian $1.34M 3.38% 2026-09-30
6 Walleye Capital LLC Custodian $1.25M 3.15% 2026-09-30
7 WOLVERINE ASSET MANAGEMENT LLC $1.09M 2.74% 2026-09-30
8 GROUP ONE TRADING LLC Custodian $810.32K 2.04% 2026-09-30
9 Simplex Trading, LLC Custodian $486.19K 1.22% 2026-09-30

JAZZ Insider Trading (Form 4)

Latest: 2026-11-10
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-11-10 Bruce C Cozadd Director Mixed
Sell −68,808 · Exer +86,500
+17,692 $180.38 -$4.46M EDGAR
2026-11-06 Patricia Carr SVP, Chief Accounting Officer Mixed
Sell −1,413 · Exer +1,250
−163 $188.49 -$151.9K EDGAR
2026-11-05 Renee D Gala President & CEO Sell (S) −1,000 $225.37 -$225.4K EDGAR
2026-11-04 Bruce C Cozadd Director Sell (S) −6,000 $215.84 -$1.30M EDGAR
2026-10-07 Renee D Gala President & CEO Sell (S) −2,000 $236.40 -$472.8K EDGAR
2026-10-05 Bruce C Cozadd Director Sell (S) −6,000 $230.33 -$1.38M EDGAR
2026-09-14 Neena M Patil EVP & Chief Legal Officer Sell (S) −1,200 $240.94 -$289.1K EDGAR
2026-09-10 Renee D Gala President & CEO Mixed
Tax −1,967 · Sell −2,000
−3,967 $244.90 -$971.5K EDGAR
2026-09-10 Mary Elizabeth Henderson SVP, Technical Operations Tax (F) −1,427 $243.01 -$346.8K EDGAR
2026-09-02 Bruce C Cozadd Director Mixed
Tax −1,219 · Sell −6,000
−7,219 $248.66 -$1.80M EDGAR
2026-09-02 Patrick G Enright Director Tax (F) −1,706 $241.42 -$411.9K EDGAR
2026-09-02 Laura Hamill Director Tax (F) −1,706 $241.41 -$411.8K EDGAR
2026-09-02 Norbert G Riedel Director Tax (F) −1,706 $241.42 -$411.9K EDGAR
2026-09-02 Mary Elizabeth Henderson SVP, Technical Operations Tax (F) −2,092 $241.41 -$505.0K EDGAR
2026-09-02 Heather Ann McSharry Director Tax (F) −1,855 $241.42 -$447.8K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

JAZZ Insider Holdings

20 insiders · @ $233.84
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Seamus Mulligan Director 1,286,254 $300.78M -$270.18M 34 2026-08-07
2 Bruce C Cozadd Director 357,567 $83.61M -$112.82M 171 2026-11-10
3 Renee D Gala President & CEO 140,394 $32.83M -$2.40M 28 2026-11-05
4 Robert Iannone EVP, Global Head of R&D & CMO 65,686 $15.36M -$22.01M 24 2026-08-31
5 Philip L Johnson EVP & Chief Financial Officer 56,431 $13.20M $1.44M 6 2026-07-02
6 Neena M Patil EVP & Chief Legal Officer 47,671 $11.15M -$14.28M 31 2026-09-14
7 Samantha Pearce EVP, Chief Commercial Officer 47,131 $11.02M -$4.92M 28 2026-08-07
8 Kenneth W O'Keefe Director 30,256 $7.08M -$87.37M 38 2025-12-04
9 Mary Elizabeth Henderson SVP, Technical Operations 23,815 $5.57M -$1.57M 12 2026-09-10
10 Patrick G Enright Director 21,278 $4.98M -$228.70M 66 2026-09-02
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

JAZZ Board & Officers

As of SEC filings through Nov 10, 2026

Directors 13

Officers 7

Changes in the last 10 years (46)
Oct 7, 2026Renee D Gala first listed as a director in an SEC filing
Dec 4, 2025Kenneth W O'Keefe reported in an SEC filing no longer being a director
Dec 1, 2025Ted W Love became a director
Aug 11, 2025Renee D Gala listed as President & CEO (previously President & COO) in SEC filings
Mar 7, 2025Robert Iannone listed as EVP, Global Head of R&D & CMO (previously EVP, G R&D and CMO) in SEC filings
Jan 22, 2025Robert Iannone listed as EVP, G R&D and CMO (previously EVP, Global Head of R&D) in SEC filings
Dec 11, 2024The company announced the departure of Bruce C Cozadd as Chairman & CEO in an SEC filing
Aug 6, 2024Samantha Pearce listed as EVP, Chief Commercial Officer (previously SVP, Head of Europe & Internat) in SEC filings
Jul 25, 2024Laura Hamill became a director
May 31, 2024The company announced the departure of Catherine A. Sohn from the board in an SEC filing
Mar 1, 2024Philip L Johnson became EVP & Chief Financial Officer
Mar 1, 2024Patrick Kennedy became a director
Feb 23, 2024The company announced the departure of Peter Gray from the board in an SEC filing
Jan 19, 2024Samantha Pearce first listed as SVP, Head of Europe & Internat in an SEC filing
Jan 19, 2024Robert Iannone listed as EVP, Global Head of R&D (previously EVP, Global Head of Research a) in SEC filings
Dec 15, 2023The company announced the departure of Kim Sablich as EVP, GM of U.S., Commercial Ma in an SEC filing
Nov 14, 2023Renee D Gala listed as President & COO (previously EVP & CFO) in SEC filings
Sep 6, 2023The company announced the departure of Daniel N Swisher JR as President and COO in an SEC filing
Aug 3, 2023Mary Elizabeth Henderson became SVP, Technical Operations
Mar 7, 2023Robert Iannone listed as EVP, Global Head of Research a (previously EVP, Global Head of R&D) in SEC filings
Not reported recently (10)
  • Finbar Larkin · Last reported as SVP, Technical Operations in an SEC filing dated Mar 7, 2023
  • Christopher J. Tovey · Last reported as EVP, COO & Managing Director E in an SEC filing dated Jul 7, 2022
  • Michael Patrick Miller · Last reported as EVP, US Commercial in an SEC filing dated Mar 13, 2020
  • Paul Treacy · Last reported as SVP, Technical Operations in an SEC filing dated Aug 14, 2019
  • Karen J Wilson · Last reported as SVP, Finance & PAO in an SEC filing dated Mar 7, 2019
  • Matthew P. Young · Last reported as EVP & CFO in an SEC filing dated Mar 7, 2019
  • Iain McGill · Last reported as SVP, Europe & Rest of World in an SEC filing dated Mar 7, 2019
  • Suzanne Sawochka Hooper · Last reported as EVP & General Counsel in an SEC filing dated Feb 27, 2019
  • Karen L. Smith · Last reported as EVP, R&D and CMO in an SEC filing dated Mar 7, 2018
  • Russell J. Cox · Last reported as EVP & COO in an SEC filing dated Dec 13, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

JAZZ Proposed Insider Sales (Form 144)

Latest: 2026-11-06
Last 30d: 4 filings · $18.1M notice value  ·  Last 90d: 23 filings · $54.2M notice value · 16 unique filers · 35% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: COZADD BRUCE C (5, $21.0M) · ROBERT IANNONE (1, $19.2M) · ANNE O'RIORDAN (1, $3.4M) · Henderson Mary Elizabeth (2, $1.6M) · RENEE D GALA (3, $1.2M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-11-06 BRUCE COZADD Director 68,808 $16.24M 2026-11-06 Morgan Stanley Smith Barney LLC … — EDGAR
2026-11-04 PATRICIA CARR Officer 1,413 $326.9K 2026-11-04 Morgan Stanley Smith Barney LLC … — EDGAR
2026-11-03 RENEE D GALA Officer, Director 1,000 $225.4K 2026-11-03 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-11-02 Bruce C Cozadd Officer 6,000 $1.30M 2026-11-02 Merrill Lynch 10b5-1 EDGAR
2026-10-08 ANNE O'RIORDAN Director 14,687 $3.36M 2026-10-08 Morgan Stanley Smith Barney LLC … — EDGAR
2026-10-06 RENEE D GALA Officer 2,000 $472.8K 2026-10-06 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-10-01 Bruce C Cozadd Officer 6,000 $1.38M 2026-10-01 Merrill Lynch 10b5-1 EDGAR
2026-09-10 NEENA PATIL Officer 1,200 $289.1K 2026-09-10 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-09-08 Henderson Mary Elizabeth Director 2,691 $664.2K 2026-09-08 ETRADE FINANCIAL CORPORATION — EDGAR
2026-09-08 RENEE D GALA Officer 2,000 $486.1K 2026-09-08 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-02
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-02 Earnings results EDGAR
2026-10-26 Earnings results EDGAR
2026-10-09 Director or officer change EDGAR
2026-09-23 Material agreement · New debt obligation EDGAR
2026-09-15 Regulation FD disclosure EDGAR
2026-08-31 Material agreement · New debt obligation · Unregistered share sale · Other events EDGAR
2026-08-25 Other events EDGAR
2026-08-10 Material agreement EDGAR
2026-08-10 Regulation FD disclosure EDGAR
2026-08-03 Earnings results EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-24 0001232524-26-000013 EDGAR
2025-02-26 0001232524-25-000011 EDGAR
2024-02-28 0001232524-24-000015 EDGAR
2023-03-01 0001232524-23-000015 EDGAR
2022-03-01 0001232524-22-000012 EDGAR
2021-02-23 0001232524-21-000016 EDGAR
2020-02-25 0001232524-20-000016 EDGAR
2019-02-26 0001232524-19-000013 EDGAR
2018-02-27 0001232524-18-000018 EDGAR
2017-02-28 0001232524-17-000024 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-02 0001232524-26-000057 EDGAR
2026-08-03 0001232524-26-000045 EDGAR
2026-05-05 0001232524-26-000025 EDGAR
2025-11-05 0001232524-25-000074 EDGAR
2025-08-06 0001232524-25-000063 EDGAR
2025-05-07 0001232524-25-000027 EDGAR
2024-11-07 0001232524-24-000086 EDGAR
2024-08-01 0001232524-24-000068 EDGAR
2024-05-02 0001232524-24-000033 EDGAR
2023-11-08 0001232524-23-000052 EDGAR
ETF Holders
131 ETFs hold JAZZ
25 shown · $2.76B total exposure · 0.33% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJH iShares Core S&P Mid-Cap ETF iShares (BlackRock) 0.47% $563.4M $120.7B 2026-11-17
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.02% $333.1M — 2026-10-31
3 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.17% $298.6M — 2026-10-31
4 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.29% $194.1M — 2026-10-31
5 XMMO Invesco S&P MidCap Momentum ETF Invesco 2.69% $164.2M — 2026-11-17
6 VXF Vanguard Extended Market ETF Vanguard 0.17% $158.9M — 2026-10-31
7 MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust SPDR (State Street) 0.47% $117.5M $25.0B 2026-11-17
8 VFLO VictoryShares Free Cash Flow ETF Nport 1.46% $113.2M — 2026-06-30
9 IJK iShares S&P Mid-Cap 400 Growth ETF iShares (BlackRock) 0.96% $96.5M $10.1B 2026-11-17
10 DFAT Dimensional US Targeted Value ETF Dimensional 0.31% $93.9M — 2026-11-17
11 SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF SPDR (State Street) 0.47% $85.9M $18.3B 2026-11-17
12 AVLV Avantis U.S. Large Cap Value ETF Avantis 0.28% $64.0M $22.7B 2026-11-17
13 IWR iShares Russell Mid-Cap ETF iShares (BlackRock) 0.11% $61.7M $57.0B 2026-11-17
14 DFAS Dimensional US Small Cap ETF Dimensional 0.19% $60.9M — 2026-11-17
15 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.07% $58.1M — 2026-11-17
16 IHE iShares U.S. Pharmaceuticals ETF iShares (BlackRock) 3.24% $55.5M $1.7B 2026-11-17
17 VHT Vanguard Health Care ETF Vanguard 0.16% $38.6M — 2026-10-31
18 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.04% $31.5M $82.5B 2026-11-17
19 FTXH First Trust Nasdaq Pharmaceuticals ETF First Trust 2.61% $28.5M $1.1B 2026-11-17
20 MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF SPDR (State Street) 0.95% $26.1M $2.7B 2026-11-17
21 JQUA JPMorgan U.S. Quality Factor ETF JPMorgan 0.24% $23.8M $9.8B 2026-11-18
22 IVOO Vanguard S&P Mid-Cap 400 ETF Vanguard 0.41% $23.8M — 2026-10-31
23 FXH First Trust Health Care AlphaDEX® Fund First Trust 1.92% $22.2M $1.2B 2026-11-17
24 DCOR Dimensional US Core Equity 1 ETF Dimensional 0.05% $21.6M — 2026-11-17
25 IWS iShares Russell Mid-Cap Value ETF iShares (BlackRock) 0.14% $20.6M $14.6B 2026-11-17
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
75.28
TTM Diluted EPS
$3.11
TTM Revenue
$4.72B
TTM Net Income
$205.95M
TTM Op. Cash Flow
$1.69B
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-09-30$1.24B$-483.40M$-7.48$506.10M
Q2 '262026-06-30$1.21B$192.80M$2.78$415.70M
Q1 '262026-03-31$1.07B$293.10M$4.43$408.20M
Q4 '252025-12-31$1.20B$203.45M$3.38$362.52M
Q3 '252025-09-30$1.13B$251.40M$4.08$474.70M
Q2 '252025-06-30$1.05B$-718.50M$-11.74$88.80M
Q1 '252025-03-31$897.80M$-92.50M$-1.52$429.80M
Q4 '242024-12-31$1.09B$191.12M$3.02$398.58M
Q3 '242024-09-30$1.05B$215.06M$3.42$398.75M
Q2 '242024-06-30$1.02B$168.57M$2.49$331.35M
Q1 '242024-03-31$901.98M$-14.62M$-0.23$267.23M
Q4 '232023-12-31$1.01B$94.15M$1.43$167.34M
Q3 2026 • period ending 2026-09-30 • filed 2026-11-02
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
75.28
P/B
3.63
P/S
3.23
EV/EBITDA
9.58
EV/Sales
3.76
ROE
4.9%
ROA
1.7%
Div Yield
0.00%
FCF Yield
11.11%
Debt/Equity
1.09
Current Ratio
—
Market Cap
$15.24B
as of 2026-11-19

JAZZ vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
LLY Eli Lilly & Co. $1.23T 43.9 +45.5% +25.2% 37
JNJ Johnson & Johnson $656.5B 40.4 +7.8% +28.4% 89
ABBV ABBVIE INC. $505.6B 48.7 +10.7% +23.3% 49
MRK Merck & Co., Inc. $339.7B 136.2 +4.9% +24.1% 56
PFE Pfizer Inc. $159.9B 39.3 +1.3% +9.2% 80
BMY Bristol-Myers Squibb Co. $121.7B 12.8 +3.1% +8.9% 78
ZTS ZOETIS INC. $34.8B 13.8 +1.0% −35.6% 19
VTRS Viatris Inc. Common Stock $23.3B — +4.3% +59.2% 53
JAZZ Jazz Pharmaceuticals, Inc. $15.9B 75.2 +13.5% +35.1% 23
Peer median $249.8B 40.4 +4.6% +23.7% 55

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
5.80M
SI % of Float
9.33%
Days to Cover
7.67
Short Vol Ratio
59.5%
Free Float
62.17M
Float %
95.8%
Short interest 2026-10-30 • Short volume 2026-11-18 • Float 2026-08-13